Leadership
  • Bonnie H. Anderson
    Chief Executive Officer and Chairman of the Board
    Bonnie H. Anderson
    Chief Executive Officer and Chairman of the Board
    Her career spans over 30 years in regulated diagnostics and life science markets. Ms. Anderson cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board.
    MORE ABOUT Bonnie >
  • Christopher M. Hall
    President and Chief Operating Officer
    Christopher M. Hall
    President and Chief Operating Officer
    Mr. Hall led the development and oversight of Veracyte’s commercial enterprise and operations. This included overseeing the successful launch of the company’s three products, including its market-leading Afirma® Gene Expression Classifier, which is becoming the new standard of care in thyroid cancer diagnosis.
    MORE ABOUT Christopher >
  • Keith Kennedy
    Chief Financial Officer
    Keith Kennedy
    Chief Financial Officer
    Mr. Kennedy was President and Chief Executive Officer of MCG Capital Corporation, where he led strategy and operations for the publicly held commercial finance company and held various Board roles for its portfolio companies in health care and other industries.
    MORE ABOUT Keith >
  • Neil M. Barth, M.D.
    Chief Medical Officer
    Neil M. Barth, M.D.
    Chief Medical Officer
    Neil served as Chief Medical Officer for Agendia NV, a molecular diagnostics company focused on oncology, where he guided the company’s medical strategic direction, quality initiatives, and interface with regulators and payers. Dr. Barth previously served as Chief Medical Officer for Ambry Genetics, a clinical genetics diagnostics company.
    MORE ABOUT Neil >
  • Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and SVP of Research and Development
    Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and SVP of Research and Development
    Dr. Kennedy’s scientific leadership, Veracyte continually pushes the boundaries of what is possible in genomic diagnostics, using big data and machine learning to develop tests that answer critical clinical questions.
    MORE ABOUT Giulia >
  • John W. Hanna
    Chief Commercial Officer
    John W. Hanna
    Chief Commercial Officer
    John has held senior management positions including Vice President of Marketing and Vice President of Endocrinology. During his tenure, Mr. Hanna has helped define clear patient-centric value propositions for Veracyte’s genomic tests, leading to their broad physician adoption and payer reimbursement.
    MORE ABOUT John >
  • Ashish Kheterpal
    Chief Information Officer
    Ashish Kheterpal
    Chief Information Officer
    Mr. Kheterpal has led Veracyte’s technology development and deployment in support of the company’s infrastructure, operations and product development as it has grown to a three-product company with over $65 million in annual revenue.
    MORE ABOUT Ashish >
  • Julie Brooks
    Executive Vice President, General Counsel and Secretary
    Julie Brooks
    Executive Vice President, General Counsel and Secretary
    Julie brings over 25 years of experience as a general counsel and executive team member, primarily for NASDAQ-listed and venture-backed multi-national medical device, biotechnology and healthcare IT companies. Most recently, she served as Vice President, General Counsel for Bayer HealthCare LLC.
    MORE ABOUT Julie >